Replies to post #143866 on Biotech Values

[genisi]

I don't know of any. Aptamers can be easily modified chemically with a variety of functional groups and can bind to antibodies (this is used in the design of an aptamer-antibody hybrid sandwich ELISA), so while not trivial, I don't think it's impossible.

[genisi]

Bet it would be easier to co-formulate Fovista with AGN's DARPin :)